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Size-Exclusion Chromatography-
based isolation minimally 
alters Extracellular Vesicles’ 
characteristics compared to 
precipitating agents
Ana Gámez-Valero1,2, Marta Monguió-Tortajada1, Laura Carreras-Planella1, 
Marcel·la Franquesa1, Katrin Beyer2 & Francesc E. Borràs1,3
Extracellular vesicles (EVs) have become an attractive field among the scientific community. Yet, a 
major challenge is to define a consensus method for EVs isolation. Ultracentrifugation has been the 
most widely used methodology but rapid methods, including Size Exclusion Chromatography (SEC) 
and/or precipitating agents such as Polyethylene glycol (PEG) or PRotein Organic Solvent PRecipitation 
(PROSPR) have emerged. To evaluate the impact of these different methods on the resulting EV 
preparations, plasma EVs were isolated using SEC, PEG and PROSPR, and their total protein content, 
NTA and Cryo-electron microscopy profiles, and EV-markers were compared. Also, their effect on 
recipient cells was tested. Low protein content and Cryo-EM analysis showed that SEC removed most 
of the overabundant soluble plasma proteins, which were not removed using PEG and partially by 
PROSPR. Moreover, only SEC allowed the detection of the EV-markers CD9, CD63 and CD81, LGALS3BP 
and CD5L, suggesting a putative interference of the precipitating agents in the structure/composition 
of the EVs. Furthermore, PEG and PROSPR-based EV isolation resulted in reduced cell viability in vitro. 
These results stress that appropriate EV-isolation method should be considered depending on the 
forthcoming application of the purified EVs.
The vast majority of eukaryotic cells release extracellular vesicles (EVs), which are involved in cell-cell commu-
nication and also pathogenic processes1. EVs have also been envisaged as drug and gene delivery vectors for 
cell-free therapeutic approaches2,3. In addition, due to their particular composition and their presence in several 
body fluids such as blood, urine or saliva among others4–6, EVs have importantly emerged as potential reservoirs 
of biomarkers for many pathological processes and patients’ follow-up7,8. One of the major drawbacks in the 
development of EVs as potential biomarkers is their sometimes time-consuming isolation procedures, which 
involve density gradients and differential ultracentrifugation9. These techniques cannot be easily adapted to the 
clinical labs, boosting the development of alternative methodologies and approaches for EVs isolation10.
In this sense, new methods based on aggregating agents such as polyethylene glycol (PEG), or size-exclusion 
and immunoaffinity columns have been described11–15. More recently, PRotein Organic Solvent PRecipitation 
(PROSPR) has been reported as a new feasible EV-purification protocol based in protein precipitation by cold 
acetone16. Although most of these methods meet the expectations of quickly obtaining EVs for biomarker 
determination in a clinical setting, the final composition of the “isolated” EVs, the abundance of contaminating 
proteins and the effect of the isolation technique on the EVs is still a matter of controversy. In this study, we 
aimed to characterize the EVs isolated from plasma and cell culture samples using three different methods, Size 
Exclusion Chromatography (SEC), PEG and PROSPR, to compare how each method influences the obtained EV 
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preparation. Our results suggest that, although vesicles could be isolated by PROSPR and SEC protocols, only SEC 
seems not to alter the size and the vesicular characteristics.
Results and Discussion
Protein content from isolated EVs. The starting volume of platelet-free plasma used for each isolation 
method was 2 mL. From this initial volume, precipitation of EVs using PROSPR and PEG rendered a final volume 
of 1 mL and 500 μ L, respectively (Fig. 1). Using SEC, EVs from the initial 2 mL of platelet-free plasma were finally 
distributed in several tetraspanin-positive fractions of 500-μ l (Figs 1 and 2A), which were pooled in a single tube 
of 1.5 mL volume.
Figure 1. Schematic representation and description of the main steps involved in the three methodologies 
used for the isolation of EVs. 
Figure 2. Protein content of EVs is dependent of the isolation method. (A) Representative experiment of 
plasma-derived EVs eluted in low protein fractions after SEC isolation. A total of 20 fractions of 0.5 mL were 
collected and the presence of tetraspanins CD9, CD63, CD81 and total protein content were determined. The 
three top MFI tetraspanin fractions of each experiment were pooled for further analyses. A representative 
sample of five independent experiments is shown. The isotype negative control is represented as a dashed line. 
(B) Protein concentration from different EV-enriched preparations measured by absorbance at 280 nm and 
calculated using a BSA standard curve. Protein content from SEC-EVs was determined in the pooled fractions. 
Five independent experiments are shown.
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First, the total protein of the obtained EV preparations was estimated by measuring the absorbance at 
280 nm in five different independent samples. While PROSPR samples rendered a mean of 3.9 mg of total pro-
tein (3.9 ± 1.1 mg, n = 5), PEG-precipitation resulted in 5 times increased protein content (21.1 ± 10.4 mg, n = 5) 
(Fig. 2B). Conversely, protein content was undetectable in SEC-pooled EV fractions (0.3 ± 0.3 mg, n = 5), as most 
of the soluble proteins eluted in later fractions (fraction 15 onwards in Fig. 2A), devoid of EVs as revealed by the 
absence of tetraspanin markers. Thus, high quantities of soluble plasmatic proteins are pelleted along with EVs 
when using precipitating methods. Therefore, attention should be paid when these EV-enriched samples are sub-
jected to proteomic analysis as EV-related proteins might be masked by over-represented plasma proteins. While 
a huge part of these soluble contaminants are not to be co-precipitated by cold acetone precipitation, as revealed 
by a lower protein content, the undetectable amount of total protein still point to SEC as the cleanest isolation 
method removing most of the overabundant plasma proteins.
EV characterization by flow cytometry and western blot. The presence of some classical exosomal 
markers -tetraspanins CD9, CD63 and CD81- was determined by bead-based flow cytometry and used to iden-
tify fractions containing EVs in SEC isolation (Fig. 2A). The presence of all the three tetraspanins was clearly 
confirmed on SEC pooled EV-enriched fractions (Fig. 3A). However, when tetraspanins were evaluated in PEG 
and PROSPR preparations from the same samples, CD63 and CD81 were undetectable. Only CD9 could be deter-
mined in samples obtained by PEG but not when using PROSPR (Fig. 3A). Of note, Gallart -Palau et al.16 reported 
the presence of tetraspanins CD9 and CD63 in PROSPR-EVs samples by western blot. Nevertheless, in our flow 
cytometry analyses performed using non-altered EVs the presence of these tetraspanines could be detected, thus 
Figure 3. EV markers detection by flow cytometry and Western blot analysis. (A) MFI values of the 
tetraspanins CD9, CD63 and CD81 in the SEC-pooled fractions, PEG precipitate and PROSPR product by 
bead-based flow cytometry. Bars represent mean+ /− SD of four independent experiments. Differences with 
*P < 0.05, and **P < 0.005, were considered statistically significant by One-way ANOVA, Tukey test. (B) 
Western blot analyses of CD5L and LGALS3BP proteins from SEC isolated EVs, PEG and PROSPR products. 
SEC-EVs were concentrated using a 100 kDa-Amicon Ultra and dehydrated in a vacuum concentrator. Three 
different PROSPR concentrating preparations were loaded. First, the supernatant from PROSPR protein 
precipitation was dehydrated in a vacuum concentrator (miVac Quattro) at room temperature, and resuspended 
in 1 mL as originally reported (i). To further concentrate the sample, (i) was then ultrafiltered as in SEC samples 
and dehydrated to 30 μ L of final volume (ii). Alternatively, the 5000× g supernatant was directly concentrated 
using the 100 kDa-Amicon Ultra (Millipore), reaching a final volume of 100 μ L (iii). (C) Ponceau S Staining of 
the blotting membrane.
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facilitating their determination. Regarding PEG-isolation, it is possible that some epitopes for CD63 and CD81 
could be altered by the isolation method, or masked by other contaminant proteins present in the sample.
To further extend the analyses of EV samples, the presence of LGALS3BP and CD5L was also deter-
mined using western blot. These markers have been previously described in several proteomic analyses of 
plasma-derived EVs13. While both LGALS3BP and CD5L were detected in SEC and PEG preparations, surpris-
ingly no expression was found in PROSPR-enriched samples (Fig. 3B). The membrane was also stained with 
Ponceau S Solution to visualize the purity of the different loaded samples (Fig. 3C). Despite similar amount of 
total protein (based on absorbance at 280 nm) were loaded in each case, an unexpected result was that only in 
ultrafiltered PROSPR-vesicles some stained protein was detected in the membrane. Nevertheless, the PROSPR 
samples were negative for both widely accepted EV markers. These results suggest that SEC-EV isolation mini-
mally affect EV composition and permits the detection of EV markers using different methods.
EV characterization by NTA and Cryo-EM. To further characterize the isolated EVs obtained from 
each isolation method, concentration and size distribution of EVs were determined in SEC-pooled EVs and 
PROSPR and PEG preparations by Nanoparticle Tracking Analysis (NTA) (Fig. 4). SEC-purified EVs yielded 
1.9E + 10 particles/mL with an average modal size of 116.4 ± 7.7 nm (median ± SD, n = 4). PROSPR purifica-
tion clearly increased the concentration (3.3E + 11 particles/mL), although showed a slightly higher particle size 
(136.0 ± 18.4 nm, n = 4). Finally, PEG-isolated EVs resulted in a 2-log increase of particles compared to SEC 
(1.0E + 12 particles/mL) with equivalent size (116.0 ± 15.4 nm n = 4). The NTA profiles also showed a major peak 
of abundant vesicles of around 110 nm to 120 nm for SEC and PEG preparations, whilst PROSPR showed several 
peaks, some of them well over 200 nm (Fig. 4A).
To better delineate EV characteristics, isolated vesicles were analysed using cryo-EM. Microscopy images 
revealed the presence of 80–200 nm sized vesicles in the SEC-pooled fractions (Fig. 5A). Images also showed 
very few contaminant particles in these preparations. Conversely, we were not able to visualize any vesicles in the 
PEG-isolation preparation, but some dense contaminant aggregates (Fig. 5B). As for EVs obtained by PROSPR, 
an unexpected observation was that most of them appeared merged in concentric multi-layer vesicles (Fig. 5C), 
which could explain the increased size found in NTA experiments. The compilation of EV sizes gathered from 
several cryo-EM images also confirmed the results of the NTA analysis (Fig. 6). Given the cryo-EM profile of the 
PROSPR isolated vesicles, it is tempting to speculate that specific antibodies did not detect tetraspanins by flow 
cytometry in the native structure of the vesicles due to EV fusion. Our current results cannot clarify whether 
PROSPR-EVs have fused or are artificially multilayered during the Cryo-microscopy preparation. Some studies 
described a “degradative” potential of organic solvents such as acetone, which could increase the membrane fluid-
ity and therefore fusion17. Comparatively, multilayering is scarce in cryo-microscopy preparations from SEC-EVs, 
thus indicating that the observed pattern may not be attributed to random distribution.
Cryo-EM results indicate that SEC yields individual, clean EVs while PEG seems to co-precipitate proteins and 
contaminants, whilst cold acetone precipitation could induce vesicular fusion, which may affect the membrane 
Figure 4. EVs characterization by Nanoparticle Tracking Analysis (NTA). (A) Representative size 
distribution profiles of EVs isolated by SEC, PEG or PROSPR precipitation. (B) Concentration (particles/mL) 
and (C) modal size (nm) of EV samples according to NTA measures. The median + /− SD is reported for four 
independent experiments from four individual samples carried out in parallel with each method.
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Figure 5. Cryo-EM images. (A) Pooled SEC fractions showed single vesicles of size between 80–200 nm. (B) 
No vesicles were found in Cryo-EM images from PEG precipitated samples. Electron dense particles covered 
the whole grid indicating co-precipitation of contaminants. (C) PROSPR isolated vesicles were visualized as 
concentric multi-layered vesicles, mostly measuring from 300 to 500 nm. Scale bars are shown for each image.
Figure 6. Distribution of the diameter (nm) of vesicles found in SEC and PROSPR preparations. Vesicles 
detected in Cryo-EM images from either SEC (143 vesicles) or PROSPR (113 vesicles) preparations were 
counted and the diameter measured using Image J Program. PEG isolated EVs were not detected in Cryo-EM 
images.
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and properties of the isolated vesicles. Considering all the observations, the putative interference of the isolation 
methods in the structure and/or composition of the vesicles should be taken into account depending on their 
forthcoming application.
Effect of isolated EVs on in vitro cultured cells. The variable results in protein content, vesicular size 
and detection of tetraspanins of the different EV preparations could also suggest modifications in the vesicular 
properties that may affect their function. A preliminary approach to evaluate the effect of the different isolation 
protocols on EV’s function was to observe their impact in the survival of different cells when added in vitro. Using 
the human monocytic cell line THP-1 as a source of EVs, vesicles were isolated from cell culture supernatants 
(106 EV producing cells) using the three different methodologies. Then, 105 target cells were cultured in the pres-
ence of EVs and cell viability was evaluated at different time points.
Target cells included the THP-1 cell line itself and THP-1-derived macrophages. In all the conditions tested, 
cell viability was faintly affected up to 3 hours when EVs derived from SEC and PROSPR were added (Fig. 7). In 
contrast, THP-1-derived macrophages exposed to PEG-isolated vesicles showed a clearly reduced viability after 
1 and 3 hours at 37 °C (Fig. 7B). When cells were analyzed at longer time points (24 h), the reduced cell viability 
observed in PEG-EV treated cultures did not show further reduction, while THP-1 and also macrophages dra-
matically decreased viability when exposed to PROSPR-derived vesicles (Fig. 7 and Supplemental Fig. 1, panels 
Di,ii). Noticeably, cultures with SEC-EVs had similar behaviour compared to control conditions in all time points 
tested. These results clearly suggest that some of the methods used to isolate EVs may affect cell viability, an 
additional aspect to be considered when choosing the EV isolation to be used in functional assays and possible 
clinical applications.
To summarize, the results of this study show that EV isolation methodologies differently affect the vesicle 
preparations and alter EV profiles (summarized in Table 1). In this line, although precipitating agents could 
represent a quick and easy method suitable for implementation in the clinics, our results suggest that they could 
hamper EV-associated proteome discovery and be especially detrimental for therapeutic applications of EVs. In 
this sense, a recent study has referred to the influence of isolation methods in the biological activity of EVs, as 
they probably affect EV-membrane interactions18. The toxicity of PEG- and PROSPR-derived EV preparations 
observed in some cell lines should receive special attention when using these vesicles in clinical applications for 
EV-based therapies. Finally, our results suggest not only that SEC is capable of removing most of the abundant 
Figure 7. EV effect on cell viability. (A) Viability of THP-1 cells and (B) THP-1-derived macrophages 
incubated with THP-1-EVs from SEC, PEG or PROSPR isolation. The results are expressed as the percentage of 
viable cells relative to the control condition (PBS) in each particular experiment. Bars represent mean+ /− SD 
of 3 to 5 independent experiments. Differences with *P < 0.05, **P < 0.005, and ***P < 0.0001 were considered 
statistically significant by Two-way ANOVA, Tukey test.
Size Exclusion 
Chromatography (SEC)
PolyethyleneGlycol 
(PEG)
PRotein Organic Solvent 
PRecipitation (PROSPR)
Initial Volume (mL) 2 2 2
Final Volume (mL) 1.5 0.5 1
Final protein content (mg) of resulting EV preparation 0.3 ± 0.3 21.1 ± 10.4 3.9 ± 1.1
Tetraspanins detection CD9+ /CD63+ /CD81+ CD9+ /CD63− /CD81− CD9− /CD63− /CD81− 
Other EV markers (Western Blot) LGALS3BP+ /CD5L+ LGALS3BP+ /CD5L+ Non detected
Nanoparticle Tracking Analysis Modal Size (nm) 116.4 ± 7.7 116 ± 15.4 136.0 ± 18.4
Concentration (particles/mL) 1.9E + 10 1.0E + 12 3.3E + 11
Cryo Electron microscopy Mostly single vesicles (80–200 nm) Undetectable
Concentric multi-layer 
vesicles (>200 nm)
Table 1.  Summary of the characterization of EVs isolated using the three different methodologies.
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proteins contained in a body fluid but also it maintains the vesicular structure and conformation, thus making 
this procedure ideal for biomarker discovery as well as for therapeutic applications. The main disadvantage of this 
technique could be the limited quantity of EVs recovered, although the scale-up of SEC is possible and encour-
ages its use for the EV-isolation for therapeutic uses.
Materials and Methods
Sample collection and Ethic Statement. Plasma samples were obtained from healthy donors at the 
Germans Trias i Pujol Hospital of Badalona (Spain). Informed consent was obtained from all subjects and the 
study was approved by the “Germans Trias i Pujol” Ethical Committee according to the Declaration of Helsinki 
(BMJ 1991; 302:1994). All samples were analyzed anonymously and all the methods were carried out in accord-
ance with the relevant guidelines.
Peripheral blood was collected following standard procedures that minimize contamination by platelet and 
platelet-derived vesicles19–21. Briefly, by venous puncture, the first millilitre of blood was discarded before col-
lection of 3 mL in several trisodium citrate pre-treated tubes (BD, San Jose, CA). After inversion (8–10 times), 
samples were processed within the 30 minutes of collection. Consecutive centrifugation steps at 400× g for 5 min-
utes to eliminate red blood cells and 2,500× g for 10 minutes at room temperature to minimize contamination 
by platelets and platelet-derived vesicles were performed21,22. Supernatant was subject to a final centrifugation of 
13,000× g for 5 minutes to completely obtain a platelet-free plasma sample23,24. Plasma samples were then pro-
cessed for vesicle isolation within the same day as represented in Fig. 1.
EV isolation by Size Exclusion Chromatography (SEC). Isolation of vesicles by SEC was performed 
as described by Boïng and colleagues12. Succinctly, 12 mL of Sepharose CL-2B (Sigma Aldrich, St. Louis, MO, 
USA) was stacked in a 20-mL syringe (BD PlasticpakcTM, San Jose, CA) and washed and equilibrated with PBS 
(Oxoid).
Two mL of plasma were loaded onto the column and fraction collection (0.5 mL per fraction and a total of 20 
fractions were collected) started immediately using PBS as elution buffer.
EV isolation by Polyethylene glycol precipitation (PEG). The application of polyethylene glycol in 
EVs purification has recently been reported25,26. A working solution of PEG was prepared with PEG6000 (Sigma 
Aldrich) at 50% with PBS and 75 mM NaCl. Two mL of platelet-free plasma were mixed up with 200 μ L of 
50%-PEG (final concentration of 10%), incubated on ice for 30 minutes and finally centrifuged at 1,500× g for 
30 minutes. The obtained pellets were dissolved in 500 μ L PBS.
EVs isolation by PRotein Organic Solvent PRecipitation (PROSPR). PROSPR procedure was per-
formed as recently published16. Briefly, two mL of sample were directly mixed with four times the volume of 
cold acetone (previously cooled down at − 20 °C) (QCA, Química Clínica Aplicada S.A.). After vortexing it, the 
mixture was centrifuged at 3,000× g for one minute. Extracellular vesicles are expected to be contained in the 
resultant supernatant, thus this supernatant was dehydrated in a vacuum concentrator (miVac Quattro from 
Genevac) at room temperature for approximately 1–1.5 hours. Once dried, the resultant EV-containing pellet was 
resuspended in 500 μ L PBS.
Measurement of Protein content. Protein content was measured by reading absorbance a 280 nm using 
Nanodrop® ND-1000 from Thermo Scientific. Protein concentration was calculated using a standard curve of 
bovine serum albumin (BSA) serial dilution also assessed by bicinchoninic acid assay (BCA assay) (Thermofisher 
Scientific) and Nanodrop.
Nanoparticle Tracking Analysis. Size distribution and concentration of isolated vesicles were measured in 
a NanoSight LM10 instrument (Malvern Instruments Ltd, Malvern, UK) equipped with a 638 nm laser and CCD 
camera (model F-033), and data were analyzed with the Nanoparticle Tracking Analysis (NTA) software (ver-
sions 3.1 build 3.1.46 ). To perform the measurements, detection threshold was set to 5, and blur and Max Jump 
Distance were set to auto. Samples processed by SEC were diluted 90-100 times with sterile and filtered Phosphate 
Buffered Saline (PBS) to reduce the number of particles in the field of view below 140/frame. Readings were taken 
in single capture during 60 s at 30 frames per second (fps), at camera level set to 16 and manual monitoring of 
temperature.
In the same way, preparations obtained by PROSPR and PEG aggregation were analyzed taking into account 
the same parameters.
Bead-based flow cytometry. Fractions from SEC and EV-enriched fractions from PEG and PROSPR 
were analyzed by flow cytometry to identify the classical exosomal markers CD63, CD9 and CD81. In the same 
way as previously reported14, 50 μ L of each fraction were incubated with 0.2 μ L aldehyde/sulphate-latex beads 
(4 μ m; Invitrogen, Carlsbad, CA) for 15 min at RT. Once re-suspended in 1 mL bead-coupling buffer (BCB) 
(PBS supplemented with 0.1% BSA and 0.01% NaN3; Sigma Aldrich), the mix was incubated overnight at 
RT on rotation. EV-coated beads were then spun down at 2,000× g for 10 min, washed with BCB and centri-
fuged again at 2,000× g for 10 min. EV-coated beads were then labelled at 4 °C with anti-CD9 (Clone VJ1/20), 
anti-CD63 (Clone TEA 3/18), and anti-CD81 (clone #G0709, from Santa Cruz Biotech) or polyclonal IgG isotype 
(Abcam, Cambridge, UK) antibodies for 30 min. After washing with BCB, EV-coated beads were incubated with 
FITC-conjugated secondary goat anti-mouse antibodies (SouthernBiotech, Birmingham, AL) for 30 min, washed 
twice with BCB and analyzed by flow cytometry (FacsVerse; BD Biosciences, San Jose, CA) using the FlowJo soft-
ware (Tree Star, Ashland, OR). A total of 10,000 beads were acquired for each sample and the median fluorescence 
intensity (MFI) was obtained.
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Western Blot. Samples obtained by the three methodologies were analysed for the presence EV markers by 
Western Blot. In order to load an equal protein amount into the gel electrophoresis, samples were further diluted 
or concentrated as needed. The tetraspanin-peak SEC fractions were concentrated using a 100 kDa-Amicon 
Ultra (Millipore, Merck kGaA, Darmstadt, Germany) and dehydrated in a vacuum concentrator (miVac Quattro, 
Genevac) at room temperature. PROSPR treated samples were processed in three different ways to concentrate 
the acetone-rich 5000× g supernatant. First, the procedure described16 was strictly followed, dehydrating the 
supernatant in a vacuum concentrator (miVac Quattro) at room temperature, and resuspended in 1 mL (i). To 
further concentrate the sample, (i) was then ultrafiltered as in SEC samples and dehydrated to 30 μ L of final 
volume (ii). Alternatively, the 5000× g supernatant was directly concentrated using the 100 kDa-Amicon Ultra 
(Millipore), reaching a final volume of 100 μ L (iii). Finally, PEG samples were diluted in PBS.
Equivalent protein amounts from each sample were mixed with reducing Laemmli Buffer and 
β -mercaptoethanol (Bio-rad laboratories, USA) and loaded on a Mini-protean TGX Precast Gel from Bio-rad 
laboratories. After the electrophoresis, proteins were transferred to a low fluorescence PVDF blotting mem-
brane (GE Healthcare, Life Science, Germany) and blocked in 5% non-fat milk in 0.1% Tween-20 PBS for 1 h. 
Membranes were then incubated with primary antibodies antiCD5L-Biotinylated [1:1000, R&D, BAF2797] and 
anti-LGALS3BP [1:500 Abcam, Cambridge, UK, 3G8] for 16 h at 4 °C. After three washes in PBS+ 0.1%Tween-
20, membranes were incubated with corresponding conjugated secondary antibodies (IRDye-800CW Goat pol-
yclonal anti-mouse IgG H+ L and streptavidin protein, DylLight 680 conjugate from ThermoFisher, 21848; both 
at 1:15000 dilution) for 1 h at room temperature. After three washes in PBS+ 0.1%Tween-20 and two additional 
washes in PBS, membrane was analysed using an Odyssey Infrared Imager (Li-cor). Total protein loaded in the 
gel was detected by staining the membrane with Ponceau S Solution for 5 minutes at room temperature.
Cryo electron microscopy. SEC fractions showing the highest MFI for exosomal markers by bead-based 
assay in flow cytometry were pooled, the fraction obtained by PEG precipitation and the vesicles isolated using 
PROSPR were selected (n = 1 for each method) for cryo-TEM microscopy. Vitrified specimens were prepared 
by placing 3 μ l of a sample on a Quantifoil® 1.2/1.3 TEM grid, blotted to a thin film and plunged into liquid 
ethane-N2(l) in the Leica EM CPC cryoworkstation. The grids were transferred to a 626 Gatan cryoholder and 
maintained at − 179 °C. The grids were analyzed with a Jeol JEM 2011 transmission electron microscope operat-
ing at an accelerating voltage of 200 kV. Images were recorded on a Gatan Ultrascan 2000 cooled charge-coupled 
device (CCD) camera with the Digital Micrograph software package (Gatan).
Cell culture and EV impact. The THP-1 human monocytic cell line was grown in complete medium 
composed of RPMI1640 (Gibco) supplemented with 10% Fetal Calf Serum (FBS, Gibco), 2 mM L-glutamine 
(Sigma-Aldrich) 100 U/mL penicillin (Cepa S.L), 100 μ g/mL streptomycin (Laboratories Normon S.A.), 1 mM 
sodium pyruvate and 50 μ M β -mercaptoethanol (both from Sigma-Aldrich). Cells were cultured in EV-free com-
plete medium (>16 h 100,000× g ultracentrifuged FBS) with 10 ng/mL phorbol 12-myristate 13-acetate (PMA, 
Sigma) to promote vesicle production. After incubation for 2 hours, supernatant was collected and EVs were 
isolated by the SEC, PEG or PROSPR methods as described before. The same amount of cells and derived condi-
tioned medium were processed following each of the three isolation methods.
Macrophages were derived from THP-1 cells by culturing cells with 10 ng/mL PMA for 48 h and further 24 h 
of resting. For viability assays, 100,000 cells were placed in EV-free complete medium in the presence or absence 
of EVs. After incubation for 30 min, 1, 3 or 24 hours at 37 °C, cell viability was measured by forward and side scat-
tering and 7AAD (BD Biosciences) staining in a FACSCanto II flow cytometer (BD Biosciences).
Statistical analysis. Data were tested for statistical significance by one-way or two-way ANOVA followed by 
Tukey test as indicated in the figure legends using Graph-Pad Prism software. Data were considered statistically 
significant when p < 0.05.
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